Skip to main content
Clinical Trials/CTRI/2018/05/013837
CTRI/2018/05/013837
Completed
Phase 3

DEVELOPMENT AND VALIDATION OF A TOOL FOR MEASURING AVARANA (OCCLUSION OF BODY CHANNELS) AND ASSESSMENT OF THE EFFECT OF SELECTED AYURVEDIC ANTIAVARANA DRUGS, IN METABOLIC SYNDROME

DrPriyaS0 sites220 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Participants with and without Metabolic syndrome
Sponsor
DrPriyaS
Enrollment
220
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 31, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DrPriyaS

Eligibility Criteria

Inclusion Criteria

  • The subjects with the age group of 30\-70years with and without Metabolic syndrome were included in the study. Those who were ready to give consent, for the administration of the draft tool were only included in phase 1\.In phase 2, the diagnosed cases of metabolic syndrome with newly developed Avarana tool (AMT\-MS) score above 22 were included.

Exclusion Criteria

  • Patients with other major systemic diseases and the patients who were not co\-operating with the study were excluded in both phases

Outcomes

Primary Outcomes

Not specified

Similar Trials